Why Teladoc Health's Prospects Look Better Than You Might Think
I think many investors are missing the forest for the trees when it comes to Teladoc Health (NYSE: TDOC). That's especially the case in the aftermath of the company's third-quarter update on Wednesday.
Teladoc's shares fell in after-hours trading. It wasn't because the company missed Wall Street's top- or bottom-line estimates. Actually, Teladoc beat revenue and earnings expectations.
Instead, investors once again seem to be fretting about slowing revenue growth. But a slowdown should be absolutely expected after the COVID-19 momentum that kicked into gear last year.
Source Fool.com
